You just read:

Novo Nordisk Receives FDA Approval of Saxenda® (liraglutide) injection 3 mg Label Update Including Long-Term Safety and Efficacy Data from 3-Year Trial

News provided by

Novo Nordisk

Apr 27, 2017, 11:06 ET